MIT and Harvard announce new research alliance with Novo Nordisk for treatment of diabetes & CVDs

The Broad Institute of MIT (Massachusetts Institute of Technology)  and Harvard, in the US, hav...

September 6, 2023 | Wednesday | News
Bristol Myers Squibb inks $50 M deal to treat immune-mediated diseases in Asia

US-based startup Zenas BioPharma has entered into a license and collaboration agreement with Bristol Myers Squibb Compan...

September 6, 2023 | Wednesday | News
Promising industry-academia partnership in Australia for cancer drug development

Australian pharmaceutical company Phebra and the University of Wollongong (UOW) have announced a new six-year collaborat...

August 30, 2023 | Wednesday | News
“There are many challenges in treating AD that research is trying to address, including higher-risk safety profiles and cost barriers”

Can you provide an overview of TauRx Therapeutics? TauRx is dedicated to research in neurodegenerative diseases and is ...

September 1, 2023 | Friday | Opinion
Singapore-based Specialised Therapeutics acquires rights of new oral MND therapy in Australia & NZ

Singapore-based biopharmaceutical company Specialised Therapeutics Asia (ST) will partner with Netherlands-based biotech...

August 28, 2023 | Monday | News
Hong Kong develops novel injectable hydrogel to revolutionise regenerative medicine

Researchers from the University of Hong Kong (HKU), the HKU-Shenzhen Hospital and the Princeton University, have collabo...

August 25, 2023 | Friday | News
ACTRIS unveils its new cell therapy facility to boost Singapore’s cell and gene therapy capabilities

The Advanced Cell Therapy and Research Institute, Singapore (ACTRIS) launched a new 2,000 sqm cell therapy facility...

August 4, 2023 | Friday | Company results
Singapore develops gene editing technology to fight RNA viruses

A team of scientists from A*STAR’s Genome Institute of Singapore (GIS) and the Yong Loo Lin School of Medicine, Na...

August 4, 2023 | Friday | News
Japanese research increases effectiveness of cancer detection tests using urine

A group led by researchers at Nagoya University in Japan has developed a technology to capture and release cell-free DNA...

July 12, 2023 | Wednesday | News
Avantor Singapore Hub expands to establish new cGMP manufacturing facility and QC lab

On 11 July, 2023, Avantor, Inc., a leading global provider of life sciences and advanced technology solutions, officiall...

July 11, 2023 | Tuesday | Company results
Singapore repurposes existing cancer drug to fight certain aggressive cancers

A team of scientists led by Nanyang Technological University, Singapore has found that an existing cancer drug could be ...

July 11, 2023 | Tuesday | News
Hitachi collaborates with Mass General Brigham for R&D in regenerative medicine and GCT

Hitachi, Ltd. has entered a strategic framework collaboration agreement with the world-renowned medical research institu...

July 4, 2023 | Tuesday | News
Korea develops novel hydrogel as hope for infertility and fertility challenges

The Health Insurance Review & Assessment Service revealed that over the last year, more than 370,000 Koreans sought ...

July 6, 2023 | Thursday | News
Singapore develops pain-free solution for drug delivery

Conventional ways of administering medication – by swallowing tablets, consuming bitter syrups, injections o...

July 4, 2023 | Tuesday | News
Enhancing Cell and Gene Therapy scalability in Asia using 3D manufacturing platforms with microcarrier technology

China-based CytoNiche Biotechnology, a pioneer in 3D dissolvable porous microcarriers, has opened the Center of Excellen...

July 3, 2023 | Monday | Opinion
Germany-Saudi Arabian tie up of $30 M for data-driven multiomic testing

Germany-based Centogene, the essential life science partner for data-driven answers in rare and neurodegenerative diseas...

July 3, 2023 | Monday | News
Immuno-oncology company Biosyngen opens new cell therapy GMP facility in Singapore

Biosyngen, an immuno-oncology company with technology targeting the unmet medical needs in solid tumour and lymphoma tre...

June 28, 2023 | Wednesday | Company results
Korea's SK bioscience inks agreement on influenza research with Doherty Institute in Australia

SK bioscience, a global innovative vaccine and biotech company based in South Korea, has signed a collaboratio...

June 28, 2023 | Wednesday | News